• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

New breast MR sequence triples signal-to-noise ratio

Article

Aurora Technologies will begin routinely upgrading its installed base of about 20 dedicated breast MR scanners with an acquisition capability that boosts signal-to-noise by 300%, according to the company. The upgrade, called spiral RODEO (Rotating Delivery of Excitation Off-resonance), was commercially launched at the RSNA meeting.

Aurora Technologies will begin routinely upgrading its installed base of about 20 dedicated breast MR scanners with an acquisition capability that boosts signal-to-noise by 300%, according to the company. The upgrade, called spiral RODEO (Rotating Delivery of Excitation Off-resonance), was commercially launched at the RSNA meeting.

Rather than acquiring data line-by-line, as happens in a conventional fat saturation 3D Fourier transformation, the new approach acquires data from the center of the field-of-view outward in a spiral pattern.

"With spiral RODEO, we are acquiring data 46% of the time, compared to a typical fat-sat acquisition, which does so about 9% of the time," said Dr. Steven Harms, medical director at Aurora.

Current users of the 1.5T Aurora system will get the upgrade first. Facilities that order the breast MR system will receive spiral RODEO automatically, according to Debbie Thomas, vice president of marketing for Aurora.

"Our goal is to have all existing Aurora users upgraded starting right after the RSNA meeting and going into December and next year," she said. "Then we'll continue rolling it out for new orders. The earliest of these, if someone orders today, would be February."

Spiral RODEO was cleared by the FDA almost a year ago and shown as a work-in-progress at the 2005 RSNA meeting. It entered clinical testing in June 2006 at the Breast Center of Northwest Arkansas in Fayetteville, a women's health center operated by Harms, who keeps one foot on the clinical side and the other on the corporate. Harms developed RODEO several years ago, while serving as the director of imaging research at the University of Arkansas in Little Rock.

When applied after contrast injection, this proprietary pulse sequence reduces signal from normal ductal tissue and, thereby avoids false-positive enhancement from benign lesions and dense fibroglandular tissue, according to Harms. The spiral version improves signal-to-noise by a factor of three, he said. This translates into dramatically improved acquisitions: 160 slices with images at 512 x 512 pixels.

Spiral RODEO is a proprietary capability of Aurora. The company's 1.5T scanner was specially designed with oscillating gradients to support this pulse sequence.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.